A PYMNTS Company

Peru: Minsa reveals four cases of drug price fixing

By  |  October 22, 2018
Peru: Minsa reveals four cases of drug price fixing

Peru’s Health Minister, Silvia Pessah, after announcing the first case of price-fixing agreements for the public purchase of medicines in Peru, has now also revealed that three other similar cases have been identified, which have already been notified to the corresponding authority.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Price manipulation was detected in several products, whose prices for the State appear to have risen significantly and without justification. In one example, Pessah details that a surcharge of over 10 times was discovered for a drug when compared with prices in commercial pharmacies.

    As a measure, Pessah also announced that the Ministry of Health (MINSA) would stop buying some of the affected medications, launching a new round of contracts to ensure fair prices. Affected medications include gastrointestinal and cardiovascular treatments, and some used in the treatment of Parkinson’s disease. As it is an ongoing investigation, the names of the companies or individuals involved have not been revealed.

    Full Content: El Comercio
    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.